Evidence map›Paper›PMID 33390938›Full record

ArticleFrontiers in pharmacology2020

Quality Markers for Astragali Radix and Its Products Based on Process Analysis.

Yuntao Dai, Dongbo Wang, Manjia Zhao, Lihua Yan, Chao Zhu, Pengyue Li, Xuemei Qin, Rob Verpoorte, Shilin Chen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Frontiers in pharmacology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Yuntao DaiInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Dongbo WangInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Manjia ZhaoInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Lihua YanInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Chao ZhuCollege of Medicine and Nursing, Dezhou University, Shandong, China.
Pengyue LiInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Xuemei QinChina Modern Research Center for Traditional Chinese Medicine, Shanxi University, Shanxi, China.
Rob VerpoorteNatural Products Laboratory, Institute of Biology, Leiden University, Leiden, Netherlands.
Shilin ChenInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNDezhou University · CNLeiden University · NLShanxi University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the complex nature of traditional medicines, quality control methods need to cover two aspects: compliance of raw materials with quality standards and process control. Astragali radix (AR), the roots of

Indexed as

astragali radixfingerprint analysisprocess analysisquality controlquality markers

Identifiers

PMID33390938
PMCPMC7775524
OpenAlexW3114030988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.